Gary Sender

Mr. Gary L.
Sender is an Independent Director at iBio, Inc., an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Schrödinger, Inc. and a President at Sender Consulting LLC.
He is on the Board of Directors at Apnimed, Inc., Gennao Bio, Inc., Elucida Oncology, Inc., iBio, Inc., Harmony Biosciences Holdings, Inc., Schrödinger, Inc. and Harmony Biosciences LLC.
Mr. Sender was previously employed as a Chief Financial Officer by Nabriva Therapeutics GmbH, a Chief Financial Officer by Nabriva Therapeutics Plc, a Chief Financial Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Senior Vice President-Finance by Shire Plc /Old/, a CFO, Vice President-Finance & Administration by Tengion, Inc., and a Head-Investor Relations & Treasury by Merck & Co. He received his undergraduate degree from Boston University and an MBA from Carnegie Mellon University.